[144] Stryker Corporation SEC Filing

Rhea-AI Filing Summary

Stryker Corporation (SYK) filing a Form 144 notifies the proposed sale of 1,785 common shares through UBS Financial Services on 08/20/2025 on the NYSE. The filing reports an aggregate market value of 701,620 and shows total shares outstanding of 382,164,865. The shares were acquired via RSU vesting in three tranches: 443 shares on 08/01/2023, 908 shares on 03/21/2024, and 434 shares on 08/01/2024; payments associated with those acquisitions were by wire. The filer indicates no securities sold in the past three months and affirms they possess no undisclosed material information about the issuer.

Insights

Securities Analyst

TL;DR: Routine insider notice for a small proposed sale; limited market impact given relative size versus outstanding shares.

This Form 144 documents a proposed sale of 1,785 Stryker common shares via UBS on 08/20/2025. The reported aggregate market value is 701,620, which appears sizable in absolute dollars but represents a de minimis fraction of Stryker's 382,164,865 shares outstanding. The underlying shares originated from RSU vesting across 2023–2024 and were paid by wire, indicating standard compensation settlement rather than a complex transfer. No sales in the prior three months are reported, and the filer certifies no undisclosed material information. Overall, this is a routine disclosure consistent with Rule 144 requirements.

Corporate Governance Expert

TL;DR: Compliance-focused filing showing adherence to Rule 144 procedures; governance implications are minor.

The filing is procedural: it notifies a planned sale of vested RSU shares and includes broker identification and acquisition history. The signature representation that no material nonpublic information exists is standard and important for governance compliance. Because the transaction stems from RSU vesting and no prior three-month sales are listed, there are no immediate red flags regarding concentrated insider liquidation or mandated disclosure failures. This notice supports transparent insider reporting but does not indicate governance issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	1785	701620	382164865	08/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2023	RSU Vesting	Stryker Corp			443	08/01/2023	Wire
Common	03/21/2024	RSU Vesting	Stryker Corp			908	03/21/2024	Wire
Common	08/01/2024	RSU Vesting	Stryker Corp			434	08/01/2024	Wire

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)